Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Scheherazade Sadegh-Nasseri, Ph.D.
Professor of Pathology
Research Interests: T cell tolerance; T cell activation; T cell memory survival; Molecular mechanisms in antigen processing and presentation ...read more
Dr. Scheherazade Sadegh-Nasseri is a professor of pathology at the Johns Hopkins University School of Medicine. Her research focuses on molecular mechanisms in antigen processing and presentation, T cell memory survival, T cell activation, and T cell tolerance.
Dr. Sadegh-Nasseri and her lab made the notable discovery that binding of peptides to MHC class II induces different conformations, a finding that has formed the basis for how peptide-MHC class II complexes are recognized and editted by the MHC class II accessory molecules. They have maintained a leading role in understanding mechanisms in peptide binding and the role of MHC class II accessory molecule, HLA-DM, in peptide exchange and editing. The team also reported the first cell free reductionist antigen processing system that identifies immunodominant epitopes from protein antigens for recognition by helper T cells.
Dr. Sadegh-Nasseri received her undergraduate degree from Pahlavi University in Iran and her M.Sc. in a joint program with Harvard University and Teheran University in Iran. She earned her Ph.D. from University of California at Los Angeles. She was a Cancer Research Institute Postdoctoral Scholar in Chemistry Department at Stanford University, and a Sr. Staff Fellow in Laboratory of Immunology of NIAID at NIH prior to her current department at the JHU.
- Professor of Pathology
Departments / Divisions
- Pathology - Immunopathology
Research & Publications
Dr. Sadegh-Nasseri is interested in two general areas of T cell recognition. She investigates the biophysical and biochemical processes that control formation of complexes of antigenic fragments and the MHC Class II, and addresses cellular and molecular events related to T cell tolerance.
The long-term interests of Dr. Sadegh-Nasseri’s lab include understanding the molecular basis for the generation of ligands for presentation to CD4 T cells and investigating the parameters that control activation and inactivation of CD4 T cells.
Selected PublicationsView all on Pubmed
Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Kim A, Hartman IZ, Poore B, Boronina T, Cole RN, Song N, Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S. Nat Commun. 2014 Nov 21;5:5369. doi: 10.1038/ncomms6369. PMID: 25413013
HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S. PLoS One. 2013 Aug 8;8(8):e71228. doi: 10.1371/journal.pone.0071228. eCollection 2013. PMID: 23951115
Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cells. Dalai SK, Khoruzhenko S, Drake CG, Jie CC, Sadegh-Nasseri S. Immunol Cell Biol. 2011 Nov;89(8):870-81. doi: 10.1038/icb.2011.2. Epub 2011 Mar 1. PMID: 21358746
A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Hartman IZ, Kim A, Cotter RJ, Walter K, Dalai SK, Boronina T, Griffith W, Lanar DE, Schwenk R, Krzych U, Cole RN, Sadegh-Nasseri S. Nat Med. 2010 Nov;16(11):1333-40. doi: 10.1038/nm.2248. Epub 2010 Oct 31. PMID: 21037588
HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. Chou CL, Sadegh-Nasseri S. J Exp Med. 2000 Dec 18;192(12):1697-706. PMID: 11120767
Academic Affiliations & Courses
Graduate Program Affiliation
Graduate Program in Immunology
Graduate Program in Biophysics
Graduate Program in Pathobiology